Literature DB >> 4138077

Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.

R L Simmons, A Rios.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4138077     DOI： 10.1002/1097-0142(197410)34:8+<1541::aid-cncr2820340828>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

Review 1.  [Biology of lectins and their application in clinical biochemistry (author's transl)].

Authors:  E Köttgen
Journal:  Klin Wochenschr       Date:  1977-04-15

2.  Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.

Authors:  H H Sedlacek; G Hagmayer; F R Seiler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01

4.  Loss of epithelial cell surface carbohydrates during experimental oral carcinogenesis in the rat.

Authors:  S S Prime; T J Rosser; L S Davies; C Scully
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

5.  Serum sialic acid and CEA concentrations in human breast cancer.

Authors:  A Hogan-Ryan; J J Fennelly; M Jones; B Cantwell; M J Duffy
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.